Prevention and Early Detection of Human Tumours - Second Edition - Skog, Sven;He, Ellen;Haghdoost, Siamak
59,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
30 °P sammeln
  • Broschiertes Buch

In 2014 World Health Organization (WHO) reported that during the next 25 years the number of cancer cases would increase by about 70% worldwide. In order to deal with this dramatic increase, WHO suggested to focus on prevention, early detection and early treatment of human tumour by health screening. We have worked on this topic for more than 30 years resulting in detection of precancerous lesions to enable early intervention in clinical oncology, preventing cancer progression and reducing mortality. A new model has been developed - Prevention, Early Detection and Early Treatment…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
In 2014 World Health Organization (WHO) reported that during the next 25 years the number of cancer cases would increase by about 70% worldwide. In order to deal with this dramatic increase, WHO suggested to focus on prevention, early detection and early treatment of human tumour by health screening. We have worked on this topic for more than 30 years resulting in detection of precancerous lesions to enable early intervention in clinical oncology, preventing cancer progression and reducing mortality. A new model has been developed - Prevention, Early Detection and Early Treatment Tumourigenesis - based on oxidative stress (8-oxo-dG) and a reliable tumour proliferation biomarker (human thymidine kinase 1 (HTK1) in serum (STK1). STK1 assay by IgY polyclonal antibody against HTK1 is able to discover invisible malignant tumours before the appearance of tumour loci in modern imaging. It is not only in the clinical evaluation of prognosis, recurrence risk, and survival in cancer patients but also for early tumour screening especially, showing that people with elevated STK1 levels in their blood have a 3-5 times higher risk to develop malignancy within 11 years.
Autorenporträt
Prof. Sven Skog has been in the medical research since 1978, got his PhD in 1985 in Medical Radiobiology, Karolinska Institute, Sweden. Prof. Skog is working in medical cell and molecular biology. He participates in international oncology studies and publishes in high rank scientific journals.